Antitumor Activity of TAK-285, an Investigational, Non-Pgp Substrate HER2/EGFR Kinase Inhibitor, in Cultured Tumor Cells, Mouse and Rat Xenograft Tumors, and in an HER2-Positive Brain Metastasis Model

Antitumor Activity of TAK-285, an Investigational, Non-Pgp Substrate HER2/EGFR Kinase Inhibitor, in Cultured Tumor Cells, Mouse and Rat Xenograft Tumors, and in an HER2-Positive Brain Metastasis Model

Breast cancer therapy has improved following the development of drugs with specific molecular targets, exemplified by inhibitors of human epidermal growth factor receptor-2 (HER2) or epidermal growth factor receptor (EGFR) such as trastuzumab and lapatinib. However, these drugs have little effect on...

Full description

Bibliographic Details
Main Authors: Nakayama, Akiko, Takagi, Shinji, Yusa, Tadashi, Yaguchi, Masahiro, Hayashi, Akira, Tamura, Toshiya, Kawakita, Youichi, Ishikawa, Tomoyasu, Ohta, Yoshikazu
Format: Online
Language:English
Published: Ivyspring International Publisher 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753530/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753530/

Similar Items